Northwest Secures US$0.5 Million Debt Financing Dec 25, 2008
The Company has started, and is currently enrolling patients in, a Phase I/II trial with DCVax(R) for recurrent ovarian cancer. The Company also has a second technology platform, involving monoclonal antibodies to CXCR4, which is at the late pre-clinical development stage. (PR Newswire)
Slamming Brakes On Deadly Ovarian Cancer Cells: Blocking Proteins Coded By Notorious Cancer-causing Gene Dec 25, 2008
24, 2008) Ovarian cancer cells are "addicted" to a family of proteins produced by the notorious oncogene, MYC. ... Using RNA interference (RNAi) to block c-Myc protein, Berkeley scientists, Tulsiram Prathapam and G. Steven Martin, treated lab cultures of human ovarian cancer cells that contained amplified MYC. RNAi's blocking of the c-Myc protein stopped the cancer cell cycle in its tracks ... But RNAi blocking of c-Myc protein in lab cultures in which the MYC gene was not experimentally... (Science Daily)
Maurice Dwane Brands Dec 25, 2008
Remembrances to the Ovarian Cancer Research Fund. Arrangements by Macy & Son. (OregonLive, OR -- News)
Rebates for MRI breast cancer scans Dec 25, 2008
Women at high risk of breast cancer include women with three or more close blood relatives diagnosed with breast or ovarian cancer. More details of women eligible for this Medicare rebate will be available from February 1 on MBS Online at. (NEWS.com.au)
Sensitive detection of cancer biomarkers with magnetic nanotags Dec 25, 2008
This could be especially helpful for lung cancer, ovarian cancer, and pancreatic cancer, because those cancers are hidden in the body. . (Nanowerk LLC)
Paladin Labs Inc. Acquired ViRexx Medical Corp. Dec 23, 2008
The lead product candidates for the AIT(TM) Platform include OvaRex MAb for ovarian cancer and BrevaRex MAb for breast cancer. OvaRex MAb was subject to one Phase II study examining combination chemo-immunotheray in front-line treatment, and two randomized, double blind and placebo controlled Phase III clinical trials examining immunotherapy during remission. (CCNMatthews Press Releases)
Nash students race for ill teacher Dec 23, 2008
It s been a tough year for Nash Primary School teacher Paula Cazeault since she was diagnosed with ovarian cancer in November, 2007. Paula had to go on sick leave to undergo chemotherapy treatment, but was then dealt an additional blow when her husband Paul was discovered to have throat cancer nearly 30 days later. (Weymouth News, MA)
Antacids linked to asthma in offspring Dec 22, 2008
Now, a research group from the M.D. Anderson Cancer Center at the University of Texas has found an association between disruptions in the microRNA system and the most deadly of gynecological cancers facing women today: ovarian cancer. "The challenge we face with ovarian cancer is that patients often have vague symptoms, meaning they don't come into the clinic until they already have advanced difficult-to-treat disease, " says the principal investigator of the study, Dr. Anil Sood ... To find... (Boston Globe)
Louise Orahood Ray, 54, teacher, 'Chief Ray of Sunshine' at Lovett Dec 22, 2008
Louise Orahood Ray, 54, of Atlanta died Friday of ovarian cancer at her home. The memorial service will be 2 p.m. Monday at Peachtree Christian Church. (Atlanta Journal-Constitution)
Screened baby free of cancer mutation Dec 22, 2008
If the couple had conceived naturally and the baby had inherited the altered version of the gene, called BRCA1, it would have had an 80 per cent chance of developing breast cancer and a 60per cent chance of ovarian cancer. By screening embryos during in-vitro fertilisation, doctors could be sure the child would be free of the mutation. (The Canberra Times)
Painkiller 'may cut cancer risk' Dec 21, 2008
Using paracetamol regularly could reduce the risk of ovarian cancer by almost a third, a study says ... Ovarian cancer is not one of the most common cancers, affecting about one in 60 women ... The team reviewed studies covering paracetamol and ovarian cancer from 1966 to 2004 in the UK, US and Denmark. (BBC News -- Health)
Ovarian cancer survival linked to two key proteins Dec 18, 2008
Study: chances of surviving ovarian cancer depend on levels of two tumor proteins ... The chances of surviving ovarian cancer appear to vary dramatically depending on the levels of two tumor proteins, suggesting that this type of cancer may have a more nuanced outlook than the grim statistics indicate ... About 22,430 new cases of ovarian cancer were diagnosed in the United States in 2007. (CNN -- Health)
Ovarian cancer survival linked to enzyme levels Dec 18, 2008
BEIJING, Dec. 18 (Xinhuanet) -- U.S. researchers found that high levels of two enzymes in ovarian cancer tissue are associated with survival that is nearly five times longer than the survival with lower levels, according to media reports Thursday ... About 22,430 new cases of ovarian cancer were diagnosed in the United States in 2007, according to the American Cancer Society. (Xinhua)
Scientists identify proteins that could increase ovarian cancer survival rate Dec 18, 2008
HOUSTON -- Scientists have identified two proteins in patients with ovarian cancer that, when prevalent, dramatically increase their chance for survival ... After studying nearly 250 ovarian cancer patients, scientists found that woman with high levels of two proteins named Dicer and Drosha in their tumor cells had a median survival of 11 years ... With the benefit of better understanding RNA interference in ovarian cancer, Sood and other scientists at M.D. Anderson have begun developing drugs... (KHOU.com, TX)
Dicer, Drosha, and Outcomes in Ovarian Cancer Dec 18, 2008
NEJM -- Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer ... Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer ... Background We studied Dicer and Drosha, components of the RNA-interference machinery, in ovarian cancer. (New England Journal of Medicine)
MicroRNA in Cancer Prognosis Dec 18, 2008
Ovarian cancer is the leading cause of deaths from gynecologic cancer, and although there are nomograms that use pathological variables to predict outcome for advanced-stage disease,1 few if any molecular mechanisms that accurately predict outcome and can potentially guide therapy have been identified. The article by Merritt et al.2 in this issue of the Journal provides evidence for a simple mechanism, based on the biologic characteristics of microRNAs (miRNAs), for formulating a prognosis and... (New England Journal of Medicine)
Pioneering mind-set at George Mason produces new HGH test Dec 17, 2008
The NIH cleared Petricoin and Liotta of wrongdoing in connection with a test for ovarian cancer they tried to develop with an outside firm, partnerships that now are forbidden at the federal agency ... Petricoin and Liotta published an article in The Lancet a journal considered more prestigious than the one the two had their research published in last week in 2002 detailing a new possible method of detecting ovarian cancer ... Keith A. Baggerly, an associate professor at the University of Texas... (USA Today -- Sports)
Generex Biotechnology and Pevion Biotech Announce Plans for Immunotherapeutic Vaccine Collaboration Dec 16, 2008
Within this collaboration, Generex wholly-owned immunotherapy subsidiary Antigen Express, Inc. combines Pevion Biotech's virosome technology with its own technology and is conducting trials in patients with breast, prostate and ovarian cancer. The combination of the two technologies will stimulate different portions of the immune system. (Primezone Releases)
Pad Out Your Amazon Wish List Dec 16, 2008
Even before Trussell was diagnosed with ovarian cancer in 2001she got the call telling her to report for surgery while watching the Twin Towers fallher work, as she says, "tended toward death, death, pet death, sex, love, death.'' But fierce or yearning, I love these ghostslike Miss Candace Mayes, who surrendered her place in the last lifeboat off the Titanic to a mother who died years later of guilt, in an asylum where "Her hands would climb the trellis. Her feet were never still. (Slate)
Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer Dec 15, 2008
DOXIL is indicated for the treatment of patients with ovarian cancer whose disease has progressed or recurred after prior platinum based therapy ... The company also markets treatments for recurrent ovarian cancer, rejection of transplanted organs and other serious illnesses. (PR Newswire)
Ovarian Cancer Subtypes Are Different Diseases: Implications For Biomarker Studies Dec 15, 2008
14, 2008) In a new analysis of tissue biomarkers expressed in ovarian cancer samples David Huntsman and his colleagues from Vancouver General Hospital suggest that substantial differences exist between ovarian cancer subtypes which should be reflected in patient management ... Although ovarian cancer is not the most common gynecologic cancer in women, the disease contributes a substantial burden of mortality in part because symptoms are nonspecific and the disease presents late in its course ...... (Science Daily)
Rotating breast cancer tests helps high-risk women Dec 14, 2008
The women were considered high risk if they had a family history of breast and ovarian cancer, a personal history of breast cancer, a biopsy indicating precancerous changes or a 20 percent or higher lifetime risk of developing breast cancer. Of the 334 women, 86 underwent the screening rotation and had undergone at least one MRI screening. (Scientific American)
Antisocial, Invasive Cells Are Basis Of Cancer Dec 14, 2008
2, 1999) An imbalance in how genes are expressed on a female's two X chromosomes may lead to the development of ovarian cancer in some women, University of Iowa Cancer Center researchers report in a study. (Oct. (Science Daily)
Alternating mammography and MRI may be best for high-risk women Dec 14, 2008
The women had undergone between one and four MRI screening cycles and were considered to be at high risk if they had hereditary breast and ovarian cancer syndrome, a personal history of breast cancer, a biopsy indicating atypia or lobular carcinoma in situ (LCIS), or a 20 percent or higher lifetime risk of developing breast cancer, as estimated by the Gail model. In the all-M. D. Anderson study, 86 of the 334 high-risk women (26 percent) underwent this alternating approach. (EurekAlert!)
Universal Health Care Push Visits Torrington Dec 12, 2008
Lois Pike, who survived uterine and ovarian cancer in her mid-20s, currently lives with advanced osteoporosis, osteoarthritis, fibromyalgia and spinal stenosis. When she stopped working and lost her insurance, she and her self- employed husband ended up paying a staggering $24,000 premium for health care because of her pre-existing conditions. (Litchfield County Times, CT)
A vote for Isabella Dec 12, 2008
In August 2003 Benson was diagnosed with ovarian cancer. Surgery left her unable to have children. (Sydney Morning Herald -- Australia)
BiPar Sciences Presents Interim Phase 2 Results for PARP Inhibitor BSI-201 At San Antonio Breast Cancer Symposium Dec 12, 2008
The company's lead product candidate is BSI-201, which is in Phase 2 testing for triple negative breast cancer, ovarian cancer and other malignancies. BSI-201 is a PARP inhibitor and represents a targeted approach to treating solid tumors. (Primezone Releases)
When Less Is More: Brief Inhibition Of Cancer Target Is Effective And Less Toxic Dec 11, 2008
21, 2008) In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the. (May 13, 2008) Women are living longer after breast cancer but simply surviving is not enough, Pamela Goldberg, Chief Executive, Breast Cancer Campaign, has said. (Science Daily)
Women's Health Dec 10, 2008
One in 60 women will get ovarian cancer, and more than 15,000 will die from it this year. Until now, little research has shown what women can do to lower their chances of getting this deadly disease. (CNN -- Health)
Breast is best, but many new moms stop too soon Dec 10, 2008
Moms who breastfeed have a lower risk of developing type 2 diabetes, ovarian cancer and breast cancer. Who isn't breastfeeding and why not. (CNN -- Health)
Can eating a big breakfast help you lose weight? Dec 10, 2008
We know that ovarian cancer is often diagnosed too late in women. Are these results controversial. (CNN -- Health)
Cancer doctors form rock 'n' roll band, land record deal Dec 10, 2008
Ovarian cancer, for instance, is especially devastating. It's often caught late and has a 10 to 15 percent cure rate. (OregonLive, OR -- News)
Pill use 'may cut risk of cancer' Dec 10, 2008
The reduced risk of large bowel, uterine and ovarian cancer was statistically significant ... But the same women were at reduced risk of developing ovarian cancer. (Yahoo News -- Birth Control)
Support Groups Dec 9, 2008
Tuesday, December 09, 2008. - The director for the Reflex Sympathetic Dystrophy Syndrome Support Group of Western PA has changed to Tanya Schrader, 814-873-1564. (Erie Times-News, PA)
Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology Dec 8, 2008
Voreloxin is currently being evaluated in a Phase 2 clinical trial (known as the REVEAL-1 trial) in previously untreated elderly AML patients and in a Phase 1b/2 clinical trial combining voreloxin with cytarabine for the treatment of patients with relapsed/refractory AML. In an ongoing Phase 2 single-agent trial in platinum-resistant ovarian cancer, voreloxin has shown objective responses and been generally well-tolerated. Conference Call Information. (PR Newswire)
Compound lights up spreading cancer cells Dec 8, 2008
They used the new compound to monitor the spread of breast and ovarian cancer cells in living mice, using a tiny camera known as an endoscope ... Using another cancer drug, Roche AG's Zenapax, known generically as daclizumab, and an endoscope, they imaged ovarian cancer tumors that had spread inside the abdominal cavity of living mice. (Scientific American)
McCann's cancer death prompts early detection warning Dec 8, 2008
The death of marathon runner Kerryn McCann has prompted the National Breast and Ovarian Cancer Centre (NBOCC) to urge women to be vigilant in checking for signs of the disease and not to ignore symptoms. McCann, a dual Commonwealth marathon gold medallist, died at her home near Wollongong in New South Wales overnight. (ABC Online)
Inside the influential new world of econobloggers Dec 7, 2008
Last week, the author of Calculated Risk announced that his co-blogger Tanta had died of ovarian cancer at age 47. The news flashed from blog to blog, eliciting tributes by everyone from ordinary readers to the Nobel Prize-winning economist Paul Krugman. (Boston Globe)
Warning signs Dec 7, 2008
Ovarian cancer - not a 'silent killer ... Ovarian cancer is often referred to as a "silent killer" as women are generally unaware they have it until it has spread ... She first found out she had ovarian cancer 20 years ago after suffering for some time with constant dull aching abdominal pain and frequent tiredness. (BBC News -- UK)
Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion Dec 7, 2008
The company also markets treatments for recurrent ovarian cancer, rejection of transplanted organs and other serious illnesses. For more information, visit. (PR Newswire)
Let the sun shine in ---- briefly ---- for health Dec 7, 2008
For example, studies show higher vitamin D levels are associated with a 75 percent lower incidence of colon cancer, a 50 percent lower incidence of breast cancer and a 48 percent lower incidence of ovarian cancer. The conference at UC San Diego was sponsored by GrassrootsHealth, an Encinitas-based public health group. (North County Times)
Doris J. Dungey, mortgage crisis blogger, at 47 Dec 6, 2008
WASHINGTON - Doris J. Dungey, an influential blogger who under the pseudonym Tanta wrote about the failing US mortgage industry, died of ovarian cancer Nov. 30 at Ohio State University Medical Center in Columbus. She previously lived in Upper Marlboro, Md. (Boston Globe)
Epithelial Ovarian Cancer Is Not On... Dec 6, 2008
Epithelial Ovarian Cancer Is Not One Disease: Histological Subtypes Are Different Diseases ... Epithelial Ovarian Cancer Is Not One Disease ... Epithelial Ovarian Cancer Is Not One Disease. (Suite101.com)
Blood scanner detects cancer at early stages Dec 6, 2008
"This could be especially helpful for lung cancer, ovarian cancer and pancreatic cancer, because those cancers are hidden in the body.". Wang is a senior author of a paper by the research team published earlier this week in the online edition of the Proceedings of the National Academy of Sciences. (Palo Alto Online, CA)
Blood Scanner Detects Even Faint Indicators Of Cancer Dec 6, 2008
"This could be especially helpful for lung cancer, ovarian cancer and pancreatic cancer, because those cancers are hidden in the body." ... (July 29, 2005) Scientists from the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR) have made a promising discovery that could improve the early diagnosis of breast and ovarian cancers through a ... (June 25, 2003) Scientists at the Pacific Northwest Research Institute (PNRI) in Seattle announced a new biomarker for ovarian cancer today. (Science Daily)
Men get breast cancer as well Dec 6, 2008
Figures from the National Breast and Ovarian Cancer Centre show that 109 men were diagnosed with the disease in 2004, up from 43 in 1983. In 2001 the figure was 95. (Sydney Morning Herald -- Australia)
Silver Lining Behind A Foreclosure? Dec 5, 2008
Now, Jackson, who also battled ovarian cancer while fighting to keep their home, is helping others facing foreclosure learn how they can and should fight back to make sure everything possible is done to save their homes. After her intense experience she has learned methods that work. (RealtyTimes)
Celebrated Romanian jazz singer Anca Parghel dies Dec 5, 2008
Celebrated Romanian jazz singer Anca Parghel has died following a highly publicized battle with ovarian cancer. Dorel Sandesc, a doctor at a hospital in the western city of Timisoara, says the 51-year-old Parghel died early Friday. (International Herald Tribune)
Environmental superhero leaves impressive legacy Dec 4, 2008
Those in Marblehead might not have known her, but to many outside of the town s blustery shores, longtime Marblehead resident Bavaria, who passed away last month after more than a two-year battle with ovarian cancer, was someone to be reckoned with, and someone to be remembered. From a baker s daughter to a banker, Bavaria became a major force within the male-dominated investment world. (Marblehead Reporter, MA)
BiPar Sciences to Present At the 31st CTRC-AACR Annual San Antonio Breast Cancer Symposium Dec 4, 2008
The company's lead product candidate is BSI-201, which is in Phase 2 testing for triple negative breast cancer, ovarian cancer and other malignancies. BSI-201 is a poly (ADP-ribose) polymerase (PARP) inhibitor, a targeted approach to treating solid tumors by preventing cancer cells from repairing damaged DNA, ultimately causing the cancer cells to die. (Primezone Releases)
Hospital Volunteer's Cross Stolen From Chapel Dec 4, 2008
Perna was a girl scout leader, water aerobics instructor, and had volunteered more than seven thousand hours at the Washington Hospital Center, before ovarian cancer claimed her life last January. Her family and friends filled the chapel at the hospital Tuesday to receive a brass cross with Perna's name on it from the women's auxillary. (W-USA News, DC)
Karen Gelzinis, 57; taught math, success in Hub schools Dec 2, 2008
The cause was paraneoplastic syndrome, an immune disorder brought on by ovarian cancer first diagnosed in 2004. Standing only 5 feet 1 inch, Mrs. Gelzinis taught math to full classrooms of students at English High for 19 years. (Boston Globe)
Study unmasks how ovarian tumors evade immune system Dec 1, 2008
Ovarian cancer is considered to be one of the most aggressive malignancies, killing more than 70 percent of diagnosed women within five years, including an estimated 15,000 this year ... As part of the study, researchers collected lipid-filled ascites from 25 women with ovarian cancer and then exposed the lipid samples to an immune system test to see if they blocked activation of NKT cells ... But until now, there was no firm evidence that tied a specific T cell in the body's defensive immune... (EurekAlert!)
'In Her Eyes': Poetry from the Hands of a Survivor and Medical Doctor Nov 29, 2008
She was raped for years by her grandfather as a child, had a near-death experience and broke both legs while mountain climbing at 20, confronted her alcohol dependency in 2004, then was diagnosed with ovarian cancer in 2006 ... And so, when she was diagnosed with ovarian cancer and started treatment, she was reflective, open and ready to allow her poetry to flow. (PR Newswire)
Jacqueline M. Belousek Nov 29, 2008
Remembrances to the Sheri Hildreth Ovarian Cancer Foundation in care of the OHSU Cancer Institute. Arrangements by Omega. (OregonLive, OR -- News)
Momentum builds in Valley's cancer research efforts Nov 29, 2008
In July, and Eli Lilly & Co. scientists discovered a recurring mutation of a specific gene in breast, colorectal and ovarian cancer. Jeff Trent, scientific director at TGen, said this could have a significant impact on cancer treatment and drug development. (Phoenix Business Journal, AZ)
Tumor Environment Determines Whether The Cellular Process Autophagy Enables Cancer Cells To Live Or Die Nov 28, 2008
Expression of the gene ARHI is lost or downregulated in most cases of ovarian cancer. In the study, in vitro re-expression of ARHI in multiple human ovarian cancer cell lines induced autophagy and cell death ... Lu et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. (Science Daily)
Warm hearts trump frigid weather Nov 27, 2008
The Soul Sisters are donating proceeds to the Kingston Recreation Center and Public Library, and to support the fight against breast and ovarian cancer. Loading commenting interface. (Kingston Mariner, MA)
Breast Cancer Common Among Women With Family History But Without BRCA1 Or BRCA2 Nov 27, 2008
2, 2005) Women diagnosed with early stage, non invasive breast cancer who carry the same mutations in two inherited breast/ovarian cancer genes as women diagnosed with invasive breast cancer, may ... 27, 2005) One in five women diagnosed with breast or ovarian cancer who seek mammography have a family history of cancer that suggests they may harbor known cancer-causing gene mutations. (Science Daily)
Study Reveals Smoking's Effect On Nurses' Health, Death Rates Nov 27, 2008
22, 2008) A new study has found that cigarette smoking and alcohol consumption do not have an effect on ovarian cancer risk, while caffeine intake may lower the risk, particularly in women not using. . (Science Daily)
Let's be Neighbors Nov 27, 2008
She had suffered many months with ovarian cancer. Our sympathy goes out to Jill, and Dustin, son of the Jerry Pearsons. (Louisville Winston County Journal, MS)
Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors Nov 26, 2008
In the present study, we used a tissue array composed of 27 BOVs, 78 LMPs and 23 LG TOVs to evaluate the protein expression of a subset of selected candidates identified in our previous studies (Ape1, Set, Ran, Ccne1 and Trail) or known to be implicated in epithelial ovarian cancer disease (p21, Ccnb1, Ckd1). Results. (BioMed Central)
MARY A. DICHTEL, 70, (2) Nov 25, 2008
died Nov. 19, 2008, at the Casa Colina Assisted Living Home in Green Valley after a courageous two-and-a-half year battle with ovarian cancer ... In lieu of flowers, donations in Mary s name can be made to the Ovarian Cancer Research Fund, 14 Pennsylvania Plaza, Suite 1400, New York, NY 10122. (Green Valley News & Sun, AZ)
'I was wacko, emotionally, during this movie' Nov 24, 2008
Her mother was the French actress Marcheline Bertrand, who died aged 56 last January from ovarian cancer. She was beautiful to me, and I look more like my mom as I get older. (Daily Mail)
Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile Nov 24, 2008
MCC is undergoing preclinical evaluation as a treatment for peritoneal carcinomatosis associated with colon and ovarian cancer. About Bioniche Life Sciences Inc. Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. (Canada Newswire)
